“Next-generation clinical trials:the contribution of emulation and in silico simulations”
This webinar, organized in collaboration with France Biotech, presents innovative approaches to molecule development in clinical research: emulation and simulation (via in silico trial modeling). Both relying on the secondary use of health data, these strategies offer new perspectives for optimizing a molecule's clinical development plan. After an overview of the regulatory context, we will describe each approach through concrete examples, highlighting their purpose and added value.
As a full-service CRO, Biotrial integrates Data Science across a wide range of preclinical and clinical research activitites - from traditional trials to real-world evidence and in-silico modeling - ensuring insights that are both scientifically sound and regulatory-ready.
*If you are using Firefox, the form might not be working. If that's the case, please reach out to us at contact@biotrial.com and we will send you the link directly. Thank you for your understanding.
Frédéric Dayan
Scientific Director –AI & In Silico Modeling, at Biotrial
Quentin Pilard
RWE Biostatistician Lead, at Biotrial
The webinar is in French, but we will be happy to schedule a meeting to discuss about this topic, in english, at your convenience.
Feel free to contact us at contact@biotrial.com if you have any questions or inquiries.
www.biotrial.com